APP/PS1 mice, compared to NLRP3 and caspase-1 knockout AD model mice, have a significantly enhanced the ability of microglia to phagocytose Aβ and differentiate microglia into anti-inflammatory M2 type, which facilitates Aβ clearance [13]. Here, APP is linked to Alzheimer disease.